Erie, CO, United States of America

Donald T Corson

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Gfb (Abc), LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donald T Corson. Retrieved from https://idiyas.com/inventor/donald-t-corson-4dng98v4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Donald T. Corson: Patent Inventor in Erie, Colorado.

Introduction

Donald T. Corson is an inventor associated with Erie, Colorado. His patent work includes a pharmaceutical formulation designed to improve the delivery of a TRPC5 inhibitor.

Latest Patents

Corson is listed as an inventor on 1 patent: “Spray-dried formulation of a pyridazinone TRPC5 inhibitor.” The patent describes spray-dried formulations of a pyridazinone compound, methods and compositions for preparing them, and solid dosage forms containing the formulations. The disclosed dosage forms are intended for use in methods addressing kidney diseases, neuropathies associated with diseases or conditions, pain, anxiety, and depression.

Career Highlights

Corson is associated with Gfb (Abc), LLC. The available information does not specify his role or the dates of his work there.

Collaborations

The patent lists Thomas E. Stumpfig and Daniel T. Smithey among Corson’s coworkers.

Conclusion

Donald T. Corson’s recorded patent contribution concerns a spray-dried pharmaceutical formulation with potential applications in treating kidney diseases, neuropathies, pain, anxiety, and depression.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…